Sign up to our newsletter
and receive exclusive information and discount coupons straight to your inbox


Top news by writer

Daniel Tomas
Tehnology Writer

HEALTH / The daily deal : a neck massager at an unbeatable price
As of this week, helpmeoutDOC has begun offering a series of massively discounted health items for sale. Today it is time to introduce our readers…
July 28, 2016 | 0 comments

Gabriel Rosoga
Medical and Health Writer

BEAUTY & SKIN CARE / Bee venom serums work miracles on skin
Bee venom, when used in small dosis, proves to be a very effective natural medicine, with extremely beneficial impact on the human organism, with particular…
September 8, 2016 | 1 comment

Ion Gireada
Science Writer

HEALTH / Reasons why your brain hears a ringing
Brain activity in people affected by tinnitus is very different from what happens when sound is detected in brains of healthy people, new research uncovered.…
April 27, 2015 | 0 comments

Ionut Popescu
Health and lifestyle writer

HEALTH / Brits oblivious to obesity leading to cancer
British population largely unware of link between obesity and cancer, finds new survey conducted by the organization Cancer Research UK. According to the survey, 75%…
September 9, 2016 | 0 comments

Melanoma survival receives boost of latest research

by Ion Gireada on 31 March 2015
Health, Lifestyle     |      melanoma,  pro-survival function,  RIP1



Melanoma
New generation of targeted and long-lasting drugs for melanoma have a high chance of becoming available, as new research unveils the double-life of a protein.

The protein known as RIP1 has a double-life, according to a study conducted by Professor Xu Dong Zhang of the University of Newcastle.

The molecule, known as Receptor-Interacting Protein kinase 1, has been known to cause the death of cells in the body, but insufficient attention has been given to its pro-survival function in melanoma cells.

According to Professor Zhang, RIP1 sits near the top of signaling pathways for melanoma. By controlling its levels should result in a reduction of subsequent signals, and prevent further tumor growth.

“We started investigating RIP1 from a perspective of necrotic cell death before finding that it actually plays an important role in regulating melanoma cell survival … we had to turn our entire thinking around,” Professor Zhang says. “It appears to be unregulated [have elevated levels] from the earliest stages of melanoma so if we can inhibit the molecule’s survival mechanism we believe we’ll be able to kill melanoma cells, either alone or in combination with existing drugs.”

The results express Professor Zhang’s opinion that the protein drives melanoma proliferation independent of other factors including genetic mutations.

Findings of the study has caught the attention of other research institutes, including cell biologists at the Paris Descartes University, and future collaborations are highly possible.

The results were published in journal Cancer Research.



Melanoma survival receives boost of latest research



Melanoma
facebook pinterest google+